BC
Brunswick CorpTrades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-05-26 | FOULKES DAVID M |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.60 to $83.53 inclusive. Beneficial holdings include 889 shares acquired pursuant to dividend reinvestment in March 2026. |
Common Stock
|
25,853 |
| 2026-05-01 | COOPER NANCY E |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.35 to $79.40 inclusive. |
Common Stock
|
194 |
| 2026-04-30 | SINGER DAVID V |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
415 of these shares are deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company. Beneficial holdings include 168 shares acquired pursuant to dividend reinvestment through March 2026. |
Common Stock
|
989 |
| 2026-04-30 | WOOD ROGER |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company. Beneficial holdings include 424 shares acquired pursuant to dividend reinvestments through March 2026. |
Common Stock
|
551 |
| 2026-04-30 | FLAHERTY LAUREN PATRICIA |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company. Beneficial holdings include 108 shares acquired pursuant to dividend reinvestments through March 2026. |
Common Stock
|
527 |
| 2026-04-30 | EVERITT DAVID C |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company. Beneficial holdings include 241 shares acquired pursuant to dividend reinvestments through March 2026. |
Common Stock
|
704 |
| 2026-04-30 | MCCLANATHAN JOSEPH W |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Beneficial holdings include 137 shares acquired pursuant to dividend reinvestment through March 2026. |
Common Stock
|
527 |
| 2026-04-30 | WHISLER J STEVEN |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company. Beneficial holdings include 578 shares acquired pursuant to dividend reinvestments through March 2026. |
Common Stock
|
970 |
| 2026-04-30 | Wright MaryAnn |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company. Beneficial holdings include 67 shares acquired pursuant to dividend reinvestment through March 2026 |
Common Stock
|
547 |
| 2026-04-30 | COOPER NANCY E |
Director |
Award↑
|
Common Stock
|
555 |
| 2026-04-30 | Fils-Aime Reginald |
Director |
Award↑
|
Common Stock
|
566 |
| 2026-02-19 | COOPER NANCY E |
Director |
Sell↓
|
Common Stock
|
192 |
| 2026-02-17 | Gwillim Ryan M |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.58 to $88.09 inclusive. |
Common Stock
|
12,785 |
| 2026-02-13 | ALTMAN RANDALL S |
SVP and Controller |
Tax↓
|
Common Stock
|
677 |
| 2026-02-13 | Buelow John G |
EVP & President Mercury Marine |
Tax↓
|
Common Stock
|
2,046 |
| 2026-02-13 | ALTMAN RANDALL S |
SVP and Controller |
Tax↓
|
Common Stock
|
776 |
| 2026-02-13 | Wrobel Jill |
EVP Chief Human Resources Off |
Tax↓
|
Common Stock
|
1,877 |
| 2026-02-13 | FOULKES DAVID M |
Director |
Tax↓
|
Common Stock
|
20,757 |
| 2026-02-13 | Dekker Christopher F |
E.V.P. GEN COUNSEL & SECRETARY |
Tax↓
|
Common Stock
|
1,441 |
| 2026-02-13 | FOULKES DAVID M |
Director |
Tax↓
|
Common Stock
|
7,869 |
| 2026-02-13 | Denari Aine |
Director |
Tax↓
|
Common Stock
|
1,044 |
| 2026-02-13 | ALTMAN RANDALL S |
SVP and Controller |
Tax↓
|
Common Stock
|
277 |
| 2026-02-13 | Denari Aine |
Director |
Tax↓
|
Common Stock
|
2,142 |
| 2026-02-13 | Wrobel Jill |
EVP Chief Human Resources Off |
Tax↓
|
Common Stock
|
1,271 |
| 2026-02-13 | FOULKES DAVID M |
Director |
Tax↓
|
Common Stock
|
11,271 |
| 2026-02-13 | Gwillim Ryan M |
Director |
Tax↓
|
Common Stock
|
4,101 |
| 2026-02-13 | Gwillim Ryan M |
Director |
Tax↓
|
Common Stock
|
1,094 |
| 2026-02-13 | Gwillim Ryan M |
Director |
Tax↓
|
Common Stock
|
1,955 |
| 2026-02-13 | Dekker Christopher F |
E.V.P. GEN COUNSEL & SECRETARY |
Tax↓
|
Common Stock
|
742 |
| 2026-02-13 | Preisser Brenna |
E.V.P. & President Boat Group |
Tax↓
|
Common Stock
|
1,497 |
| 2026-02-13 | Preisser Brenna |
E.V.P. & President Boat Group |
Tax↓
|
Common Stock
|
871 |
| 2026-02-13 | Buelow John G |
EVP & President Mercury Marine |
Tax↓
|
Common Stock
|
832 |
| 2026-02-13 | Preisser Brenna |
E.V.P. & President Boat Group |
Tax↓
|
Common Stock
|
2,142 |
| 2026-02-13 | Dekker Christopher F |
E.V.P. GEN COUNSEL & SECRETARY |
Tax↓
|
Common Stock
|
2,029 |
| 2026-02-13 | Wrobel Jill |
EVP Chief Human Resources Off |
Tax↓
|
Common Stock
|
871 |
| 2026-02-13 | Buelow John G |
EVP & President Mercury Marine |
Tax↓
|
Common Stock
|
1,566 |
| 2026-02-13 | Denari Aine |
Director |
Tax↓
|
Common Stock
|
1,555 |
| 2026-02-12 | ALTMAN RANDALL S |
SVP and Controller |
Award↑
Filing footnotes — Common Stock (Direct)
Beneficial holdings include 305 shares acquired pursuant to dividend reinvestment through December 2025. |
Common Stock
|
4,930 |
| 2026-02-12 | Gwillim Ryan M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Beneficial holdings include 454 shares acquired pursuant to dividend reinvestment through December 2025. |
Common Stock
|
14,510 |
| 2026-02-12 | FOULKES DAVID M |
Director |
Award↑
|
Common Stock
|
61,220 |
| 2026-02-12 | Dekker Christopher F |
E.V.P. GEN COUNSEL & SECRETARY |
Award↑
|
Common Stock
|
6,960 |
| 2026-02-12 | Denari Aine |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Beneficial holdings include 260 shares acquired pursuant to dividend reinvestment through December 2025. |
Common Stock
|
7,540 |
| 2026-02-12 | Wrobel Jill |
EVP Chief Human Resources Off |
Award↑
Filing footnotes — Common Stock (Direct)
Beneficial holdings include 448 shares acquired pursuant to dividend reinvestment through December 2025. |
Common Stock
|
6,380 |
| 2026-02-12 | Buelow John G |
EVP & President Mercury Marine |
Award↑
Filing footnotes — Common Stock (Direct)
Beneficial holdings include 533 shares acquired pursuant to dividend reinvestment through December 2025. |
Common Stock
|
7,540 |
| 2026-02-12 | Preisser Brenna |
E.V.P. & President Boat Group |
Award↑
Filing footnotes — Common Stock (Direct)
Beneficial holdings include 245 shares acquired pursuant to dividend reinvestment through December 2025. |
Common Stock
|
7,540 |
| 2026-02-09 | Dekker Christopher F |
E.V.P. GEN COUNSEL & SECRETARY |
Gift↓
|
Common Stock
|
300 |
| 2026-02-06 | Dekker Christopher F |
E.V.P. GEN COUNSEL & SECRETARY |
Sell↓
Filing footnotes — Common Stock (Direct)
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.63 to $88.29 inclusive. Beneficial holdings include 355 shares acquired pursuant to dividend reinvestment through December 2025. |
Common Stock
|
4,981 |
| 2026-02-05 | FOULKES DAVID M |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.55 to $87.64 inclusive. Beneficial holdings include 4,647 shares acquired pursuant to dividend reinvestment through December 2025. |
Common Stock
|
38,266 |
| 2026-01-30 | WHISLER J STEVEN |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company. Beneficial holdings include 517 shares acquired pursuant to dividend reinvestments in December 2025. |
Common Stock
|
961 |
| 2026-01-30 | EVERITT DAVID C |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company. Beneficial holdings include 215 shares acquired pursuant to dividend reinvestments in December 2025. |
Common Stock
|
697 |